vs

Side-by-side financial comparison of Emerson Electric (EMR) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.1B, roughly 1.4× Molson Coors Beverage Company). Emerson Electric runs the higher net margin — 13.9% vs 6.7%, a 7.2% gap on every dollar of revenue. On growth, Molson Coors Beverage Company posted the faster year-over-year revenue change (6.1% vs 4.1%). Molson Coors Beverage Company produced more free cash flow last quarter ($1.1B vs $602.0M). Over the past eight quarters, Emerson Electric's revenue compounded faster (-0.3% CAGR vs -9.8%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.

EMR vs TAP — Head-to-Head

Bigger by revenue
EMR
EMR
1.4× larger
EMR
$4.3B
$3.1B
TAP
Growing faster (revenue YoY)
TAP
TAP
+2.0% gap
TAP
6.1%
4.1%
EMR
Higher net margin
EMR
EMR
7.2% more per $
EMR
13.9%
6.7%
TAP
More free cash flow
TAP
TAP
$539.4M more FCF
TAP
$1.1B
$602.0M
EMR
Faster 2-yr revenue CAGR
EMR
EMR
Annualised
EMR
-0.3%
-9.8%
TAP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EMR
EMR
TAP
TAP
Revenue
$4.3B
$3.1B
Net Profit
$605.0M
$209.3M
Gross Margin
53.2%
31.0%
Operating Margin
17.8%
Net Margin
13.9%
6.7%
Revenue YoY
4.1%
6.1%
Net Profit YoY
3.4%
-28.7%
EPS (diluted)
$1.07
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
TAP
TAP
Q1 26
$3.1B
Q4 25
$4.3B
$3.1B
Q3 25
$4.9B
$3.5B
Q2 25
$4.6B
$3.7B
Q1 25
$4.4B
$2.7B
Q4 24
$4.2B
$3.2B
Q3 24
$4.6B
$3.6B
Q2 24
$4.4B
$3.8B
Net Profit
EMR
EMR
TAP
TAP
Q1 26
$209.3M
Q4 25
$605.0M
$238.3M
Q3 25
$637.0M
$-2.9B
Q2 25
$586.0M
$428.7M
Q1 25
$485.0M
$121.0M
Q4 24
$585.0M
$287.8M
Q3 24
$996.0M
$199.8M
Q2 24
$329.0M
$427.0M
Gross Margin
EMR
EMR
TAP
TAP
Q1 26
31.0%
Q4 25
53.2%
31.0%
Q3 25
51.9%
33.7%
Q2 25
52.6%
34.3%
Q1 25
53.5%
31.6%
Q4 24
53.5%
32.0%
Q3 24
51.3%
33.4%
Q2 24
52.8%
34.6%
Operating Margin
EMR
EMR
TAP
TAP
Q1 26
Q4 25
17.8%
10.4%
Q3 25
16.4%
-98.5%
Q2 25
16.1%
15.6%
Q1 25
14.2%
6.9%
Q4 24
18.6%
12.0%
Q3 24
14.7%
12.5%
Q2 24
10.4%
15.6%
Net Margin
EMR
EMR
TAP
TAP
Q1 26
6.7%
Q4 25
13.9%
7.6%
Q3 25
13.1%
-84.0%
Q2 25
12.9%
11.5%
Q1 25
10.9%
4.5%
Q4 24
14.0%
8.9%
Q3 24
21.6%
5.5%
Q2 24
7.5%
11.1%
EPS (diluted)
EMR
EMR
TAP
TAP
Q1 26
$1.22
Q4 25
$1.07
$1.32
Q3 25
$1.12
$-14.79
Q2 25
$1.04
$2.13
Q1 25
$0.86
$0.59
Q4 24
$1.02
$1.39
Q3 24
$1.74
$0.96
Q2 24
$0.57
$2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
TAP
TAP
Cash + ST InvestmentsLiquidity on hand
$896.5M
Total DebtLower is stronger
$7.6B
$3.9B
Stockholders' EquityBook value
$20.3B
$10.4B
Total Assets
$41.9B
$22.7B
Debt / EquityLower = less leverage
0.37×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
TAP
TAP
Q1 26
$896.5M
Q4 25
$896.5M
Q3 25
$950.2M
Q2 25
$613.8M
Q1 25
$412.7M
Q4 24
$969.3M
Q3 24
$1.0B
Q2 24
$1.6B
Total Debt
EMR
EMR
TAP
TAP
Q1 26
$3.9B
Q4 25
$7.6B
$6.3B
Q3 25
$8.9B
$6.3B
Q2 25
$8.3B
$6.3B
Q1 25
$8.2B
$6.2B
Q4 24
$6.6B
$6.1B
Q3 24
$7.7B
$6.2B
Q2 24
$7.1B
$7.0B
Stockholders' Equity
EMR
EMR
TAP
TAP
Q1 26
$10.4B
Q4 25
$20.3B
$10.2B
Q3 25
$20.3B
$10.3B
Q2 25
$19.9B
$13.4B
Q1 25
$19.2B
$13.1B
Q4 24
$20.5B
$13.1B
Q3 24
$21.6B
$13.3B
Q2 24
$20.8B
$13.2B
Total Assets
EMR
EMR
TAP
TAP
Q1 26
$22.7B
Q4 25
$41.9B
$22.7B
Q3 25
$42.0B
$22.9B
Q2 25
$42.5B
$26.8B
Q1 25
$42.0B
$25.9B
Q4 24
$42.6B
$26.1B
Q3 24
$44.2B
$26.6B
Q2 24
$45.6B
$27.4B
Debt / Equity
EMR
EMR
TAP
TAP
Q1 26
0.37×
Q4 25
0.37×
0.61×
Q3 25
0.44×
0.61×
Q2 25
0.42×
0.47×
Q1 25
0.42×
0.47×
Q4 24
0.32×
0.47×
Q3 24
0.36×
0.47×
Q2 24
0.34×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
TAP
TAP
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
$1.1B
FCF MarginFCF / Revenue
13.9%
36.5%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
TAP
TAP
Q1 26
Q4 25
$699.0M
$540.7M
Q3 25
$3.1B
$616.1M
Q2 25
$1.1B
$718.3M
Q1 25
$241.0M
$-90.7M
Q4 24
$777.0M
$494.5M
Q3 24
$3.3B
$521.2M
Q2 24
$1.1B
$869.2M
Free Cash Flow
EMR
EMR
TAP
TAP
Q1 26
$1.1B
Q4 25
$602.0M
$357.8M
Q3 25
$2.7B
$483.0M
Q2 25
$977.0M
$555.0M
Q1 25
$154.0M
$-328.0M
Q4 24
$694.0M
$383.4M
Q3 24
$2.9B
$350.4M
Q2 24
$998.0M
$691.7M
FCF Margin
EMR
EMR
TAP
TAP
Q1 26
36.5%
Q4 25
13.9%
11.4%
Q3 25
54.9%
13.9%
Q2 25
21.5%
14.8%
Q1 25
3.5%
-12.2%
Q4 24
16.6%
11.8%
Q3 24
63.1%
9.7%
Q2 24
22.8%
18.0%
Capex Intensity
EMR
EMR
TAP
TAP
Q1 26
Q4 25
2.2%
5.9%
Q3 25
8.9%
3.8%
Q2 25
2.0%
4.4%
Q1 25
2.0%
8.8%
Q4 24
2.0%
3.4%
Q3 24
9.1%
4.7%
Q2 24
2.1%
4.6%
Cash Conversion
EMR
EMR
TAP
TAP
Q1 26
Q4 25
1.16×
2.27×
Q3 25
4.86×
Q2 25
1.83×
1.68×
Q1 25
0.50×
-0.75×
Q4 24
1.33×
1.72×
Q3 24
3.35×
2.61×
Q2 24
3.31×
2.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

TAP
TAP

Segment breakdown not available.

Related Comparisons